US Patent Issued to INSTITUTE OF HEALTH AND MEDICINE, HEFEI COMPREHENSIVE NATIONAL SCIENCE CENTER on May 6 for "Application of a nanobody targeting on IL-6RA" (Chinese Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,573, issued on May 6, was assigned to INSTITUTE OF HEALTH AND MEDICINE, HEFEI COMPREHENSIVE NATIONAL SCIENCE CENTER (Anhui, China).

"Application of a nanobody targeting on IL-6RA" was invented by Bofeng Li (Anhui, China), Tengchuan Jin (Anhui, China) and Jiaojiao Qian (Anhui, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a nanobody targeting IL-6RAlpha protein and uses thereof, wherein the heavy chain variable region of the nanobody comprises three complementary determining regions, CDR1, CDR2, and CDR3, wherein CDR1 has an amino acid sequence as shown in SEQ ID NO. 2, CDR2 has an amino acid sequence as shown i...